A one-time gain of Rs 855 crore from the sale of its stake in Shriram Finance helped Piramal Enterprises report Rs 509 crore consolidated net profit for the April-June quarter, barring which it would have been in deep red, according to a company statement. In the June 2022 quarter, the company booked a net profit … Read more
The Indian market closed in the red for the fourth consecutive day on Monday tracking weak global cues. The S&P BSE Sensex fell by over 950 points, while the Nifty50 just managed to hold 17,000 on a closing basis. Stocks that were in focus included names like , which recouped losses and closed with a … Read more
NEW DELHI: After the demerger of the pharma and lending business in , brokerage firm has maintained a buy rating for the company with a revised target price of Rs 1,320. The brokerage sees a potential increase of nearly 37 per cent from the current market price of Rs 964.65 for the stock in the … Read more
New Delhi: , which hived off its pharmaceutical business into a separate entity, traded ex-demerger on Tuesday. The stock rose close to 9 per cent during the early trading session. The investors who bought the shares on Monday or before would have seen a more than 46 per cent fall in the stock value on … Read more